Case Report
Published on 23 Dec 2022
Akathisia after chronic usage of synthetic cathinones: A case study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1046486
- 4,599 views
Type at least 3 characters
531 articles
Articles
Original Research
Published on 22 Dec 2022
A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1033019
- 1,911 views
- 2 citations
Case Report
Published on 21 Dec 2022
Neutropenia after the coadministration of clozapine and nirmatrelvir-ritonavir in a patient with SARS-CoV-2 infection: A case report with a literature review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1096006
- 3,285 views
- 6 citations
Case Report
Published on 21 Dec 2022
Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1020214
- 8,638 views
- 2 citations
Original Research
Published on 15 Dec 2022
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1048836
- 3,800 views
- 6 citations
Case Report
Published on 14 Dec 2022
Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1037738
- 2,078 views
- 2 citations
Systematic Review
Published on 12 Dec 2022
Dual orexin receptor antagonists for treatment of insomnia: A systematic review and meta-analysis on randomized, double-blind, placebo-controlled trials of suvorexant and lemborexant
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1070522
- 7,946 views
- 6 citations
Original Research
Published on 05 Dec 2022
Moderators of ayahuasca’s biological antidepressant action
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1033816
- 6,809 views
- 6 citations
Review
Published on 05 Dec 2022
The economics of psychedelic-assisted therapies: A research agenda
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1025726
- 19,926 views
- 13 citations
Review
Published on 02 Dec 2022
Lower-dose psycholytic therapy – A neglected approach
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1020505
- 11,886 views
- 27 citations
Case Report
Published on 01 Dec 2022
Case report: Treatment of psychiatric symptoms for an acromegalic patient with pituitary adenoma
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1068836
- 2,317 views
- 3 citations
Case Report
Published on 01 Dec 2022
Patient with bipolar I disorder who presented with low blood lithium levels after receiving crushed tablets via a nasogastric tube: A case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1071721
- 2,789 views
Case Report
Published on 01 Dec 2022
The pathophysiology of rapid fluctuations in mental status associated with olanzapine: A case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1028350
- 2,487 views
- 2 citations
Review
Published on 29 Nov 2022
Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1069432
- 21,758 views
- 14 citations
Original Research
Published on 29 Nov 2022
Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1049643
- 9,340 views
- 10 citations
Original Research
Published on 17 Nov 2022
A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potential
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1016439
- 3,962 views
- 7 citations